Novo Holdings A/S’s Spruce Biosciences SPRB Stock Holding History

Novo Holdings A/S’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-89,631	Closed	-$19.7M	–	40
2023 Q4	$19.7M	Hold	89,631	–	–	1.22%	27
2023 Q3	$15.2M	Hold	89,631	–	–	1.12%	28
2023 Q2	$14.5M	Hold	89,631	–	–	1.12%	27
2023 Q1	$14.9M	Buy	89,631 +29,440	+49%	+$5.47M	0.98%	30
2022 Q4	$4.95M	Hold	60,191	–	–	0.31%	43
2022 Q3	$6.18M	Hold	60,191	–	–	0.29%	43
2022 Q2	$7.86M	Hold	60,191	–	–	0.39%	43
2022 Q1	$9.07M	Hold	60,191	–	–	0.48%	39
2021 Q4	$20.1M	Hold	60,191	–	–	0.95%	21
2021 Q3	$27.1M	Hold	60,191	–	–	1.4%	17
2021 Q2	$50.6M	Sell	60,191 -6,333	-10%	-$6.76M	2.24%	12
2021 Q1	$82.8M	Hold	66,524	–	–	3.42%	11
2020 Q4	$121M	Buy	+66,524	New	+$110M	5.2%	8

Other funds holding SPRB

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

SCM

Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Novo Holdings A/S's SPRB Position: Q1 2024 in Review

Novo Holdings A/S sold out of Spruce Biosciences (SPRB) in Q1 2024, closing a stake of 89,631 shares — an estimated $19.7M sold.

Novo Holdings A/S first reported a position in SPRB in Q4 2020 and held it in 13 quarters. The position peaked at $121M in Q4 2020. 49 funds tracked by Wall St. Rank hold SPRB as of Q1 2024.

Novo Holdings A/S reported no remaining Spruce Biosciences position as of Q1 2024 after selling out during the quarter.
Novo Holdings A/S sold 89,631 Spruce Biosciences shares in Q1 2024, an estimated $19.7M.
Novo Holdings A/S first reported a position in Spruce Biosciences in Q4 2020 and held it in 13 quarters.
Novo Holdings A/S's Spruce Biosciences position peaked at $121M in Q4 2020.
49 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2024.

Based on Novo Holdings A/S's 13F filing for Q1 2024, filed 15 May 2024.